Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 4 Stomach Neoplasms 1 Rare Tumour 1 Neoplasms 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Locally Advanced Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hereditary leiomyomatosis and renal cell cancer 1 HER2-negative Breast Cancer 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Biliary Tract Neoplasms 1

Interventions

tislelizumab 1 pamiparib 1 Injections 1 Gefitinib 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Locally Advanced Prostate Cancer × pamiparib × Clear all

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡